Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-065693
Filing Date
2023-05-30
Accepted
2023-05-30 08:00:13
Documents
3
Period of Report
2023-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2317215d1_6k.htm 6-K 13716
2 EXHIBIT 99.1 tm2317215d1_ex99-1.htm EX-99.1 3645
3 GRAPHIC tm2317215d1_ex99-1img01.jpg GRAPHIC 4519
  Complete submission text file 0001104659-23-065693.txt   24779
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 23971459
SIC: 2833 Medicinal Chemicals & Botanical Products